CA Stock MarketDetailed Quotes

BriaCell Therapeutics Corp (BCT)

Watchlist
  • 5.630
  • +0.140+2.55%
15min DelayMarket Closed May 6 16:00 ET
40.82MMarket Cap-0.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BriaCell Therapeutics Corp (BCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.58%-7.97M
-10.78%-7.7M
-16.76%-28.17M
-101.51%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
Net income from continuing operations
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Operating gains losses
80.40%-149.78K
-83.43%114.03K
98.10%-534.15K
92.39%-344.97K
98.96%-113.09K
-148.18%-764.26K
104.82%688.16K
-1,227.46%-28.14M
11.01%-4.53M
-1,922.27%-10.91M
Depreciation and amortization
0.00%26.66K
0.00%26.66K
27.09%106.63K
-63.20%26.66K
598.53%26.66K
598.01%26.66K
598.19%26.66K
449.39%83.9K
1,797.43%72.44K
-0.05%3.82K
Remuneration paid in stock
0.27%285.86K
10.38%294.69K
-56.94%776.88K
--0
-42.68%224.82K
-43.00%285.09K
-49.99%266.97K
-17.76%1.8M
-29.21%377.89K
39.48%392.22K
Other non cashItems
----
---89.49K
---56.47K
----
----
----
----
----
----
----
Change In working capital
-206.03%-922.62K
110.80%227.65K
-127.04%-1.91M
-68.59%406.44K
-128.80%-1.08M
-52.78%870.11K
-1,268.76%-2.11M
299.70%7.05M
132.79%1.29M
2,154.47%3.74M
-Change in receivables
-384.41%-790.4K
143.29%887.86K
200.14%733.63K
100.07%514
505.34%90.27K
3,281.58%277.91K
14,484.51%364.94K
-14,107.23%-732.58K
-18,411.89%-736.22K
349.87%14.91K
-Change in prepaid assets
----
----
-76.85%492.28K
-42.83%758.57K
-120.94%-185.97K
128.40%291.53K
-139.65%-371.85K
148.35%2.13M
130.43%1.33M
199.96%888.22K
-Change in payables and accrued expense
-122.33%-132.22K
73.30%-660.22K
-155.36%-3.13M
-150.13%-352.65K
-131.77%-900.21K
-79.42%592.2K
-227.51%-2.47M
557.82%5.66M
68.13%703.4K
297.57%2.83M
Cash from discontinued investing activities
Operating cash flow
-34.58%-7.97M
-10.78%-7.7M
-16.76%-28.17M
-101.51%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
Investing cash flow
Cash flow from continuing investing activities
9,809.96%7.28M
0.00%-75K
-1,021.44%-7.65M
-1,517.99%-7.39M
53.33%-105K
-75K
-75K
-681.8K
-456.8K
-225K
Net PPE purchase and sale
----
----
--0
----
----
----
----
---456.8K
----
----
Net business purchase and sale
-20.00%-90K
0.00%-75K
-46.67%-330K
---75K
53.33%-105K
---75K
---75K
---225K
--0
---225K
Net investment purchase and sale
----
----
---7.32M
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
9,809.96%7.28M
0.00%-75K
-1,021.44%-7.65M
-1,517.99%-7.39M
53.33%-105K
---75K
---75K
---681.8K
---456.8K
---225K
Financing cash flow
Cash flow from continuing financing activities
434.34%27.87M
0
928.49%45.45M
206.79%13.56M
14.71M
5.22M
11.96M
11.75%4.42M
10.47%4.42M
0
Net common stock issuance
494.48%27.87M
--0
909.91%44.63M
206.79%13.56M
--14.71M
--4.69M
--11.67M
11.79%4.42M
10.47%4.42M
--0
Proceeds from stock option exercised by employees
--0
--0
--821.02K
--0
--0
--527.76K
--293.25K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
434.34%27.87M
--0
928.49%45.45M
206.79%13.56M
--14.71M
--5.22M
--11.96M
11.75%4.42M
10.47%4.42M
--0
Net cash flow
Beginning cash position
-53.14%2.71M
1,117.25%10.49M
-95.94%862.09K
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-48.22%21.25M
-96.68%935.69K
-81.36%6.24M
Current changes in cash
3,592.07%27.19M
-257.80%-7.78M
147.24%9.63M
-2,571.62%-1.97M
240.27%7.45M
89.48%-778.61K
164.83%4.93M
-3.02%-20.39M
98.94%-73.61K
0.40%-5.31M
End cash Position
496.44%29.9M
-53.14%2.71M
1,117.25%10.49M
1,117.25%10.49M
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
Free cash from
-34.58%-7.97M
-10.78%-7.7M
-14.59%-28.17M
-81.02%-8.13M
-40.89%-7.16M
20.01%-5.92M
8.55%-6.96M
-3.53%-24.58M
58.86%-4.49M
4.65%-5.08M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.58%-7.97M-10.78%-7.7M-16.76%-28.17M-101.51%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M
Net income from continuing operations -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Operating gains losses 80.40%-149.78K-83.43%114.03K98.10%-534.15K92.39%-344.97K98.96%-113.09K-148.18%-764.26K104.82%688.16K-1,227.46%-28.14M11.01%-4.53M-1,922.27%-10.91M
Depreciation and amortization 0.00%26.66K0.00%26.66K27.09%106.63K-63.20%26.66K598.53%26.66K598.01%26.66K598.19%26.66K449.39%83.9K1,797.43%72.44K-0.05%3.82K
Remuneration paid in stock 0.27%285.86K10.38%294.69K-56.94%776.88K--0-42.68%224.82K-43.00%285.09K-49.99%266.97K-17.76%1.8M-29.21%377.89K39.48%392.22K
Other non cashItems -------89.49K---56.47K----------------------------
Change In working capital -206.03%-922.62K110.80%227.65K-127.04%-1.91M-68.59%406.44K-128.80%-1.08M-52.78%870.11K-1,268.76%-2.11M299.70%7.05M132.79%1.29M2,154.47%3.74M
-Change in receivables -384.41%-790.4K143.29%887.86K200.14%733.63K100.07%514505.34%90.27K3,281.58%277.91K14,484.51%364.94K-14,107.23%-732.58K-18,411.89%-736.22K349.87%14.91K
-Change in prepaid assets ---------76.85%492.28K-42.83%758.57K-120.94%-185.97K128.40%291.53K-139.65%-371.85K148.35%2.13M130.43%1.33M199.96%888.22K
-Change in payables and accrued expense -122.33%-132.22K73.30%-660.22K-155.36%-3.13M-150.13%-352.65K-131.77%-900.21K-79.42%592.2K-227.51%-2.47M557.82%5.66M68.13%703.4K297.57%2.83M
Cash from discontinued investing activities
Operating cash flow -34.58%-7.97M-10.78%-7.7M-16.76%-28.17M-101.51%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M
Investing cash flow
Cash flow from continuing investing activities 9,809.96%7.28M0.00%-75K-1,021.44%-7.65M-1,517.99%-7.39M53.33%-105K-75K-75K-681.8K-456.8K-225K
Net PPE purchase and sale ----------0-------------------456.8K--------
Net business purchase and sale -20.00%-90K0.00%-75K-46.67%-330K---75K53.33%-105K---75K---75K---225K--0---225K
Net investment purchase and sale -----------7.32M------------------0--------
Cash from discontinued investing activities
Investing cash flow 9,809.96%7.28M0.00%-75K-1,021.44%-7.65M-1,517.99%-7.39M53.33%-105K---75K---75K---681.8K---456.8K---225K
Financing cash flow
Cash flow from continuing financing activities 434.34%27.87M0928.49%45.45M206.79%13.56M14.71M5.22M11.96M11.75%4.42M10.47%4.42M0
Net common stock issuance 494.48%27.87M--0909.91%44.63M206.79%13.56M--14.71M--4.69M--11.67M11.79%4.42M10.47%4.42M--0
Proceeds from stock option exercised by employees --0--0--821.02K--0--0--527.76K--293.25K--0--0--0
Cash from discontinued financing activities
Financing cash flow 434.34%27.87M--0928.49%45.45M206.79%13.56M--14.71M--5.22M--11.96M11.75%4.42M10.47%4.42M--0
Net cash flow
Beginning cash position -53.14%2.71M1,117.25%10.49M-95.94%862.09K1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-48.22%21.25M-96.68%935.69K-81.36%6.24M
Current changes in cash 3,592.07%27.19M-257.80%-7.78M147.24%9.63M-2,571.62%-1.97M240.27%7.45M89.48%-778.61K164.83%4.93M-3.02%-20.39M98.94%-73.61K0.40%-5.31M
End cash Position 496.44%29.9M-53.14%2.71M1,117.25%10.49M1,117.25%10.49M1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K
Free cash from -34.58%-7.97M-10.78%-7.7M-14.59%-28.17M-81.02%-8.13M-40.89%-7.16M20.01%-5.92M8.55%-6.96M-3.53%-24.58M58.86%-4.49M4.65%-5.08M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.10%
Sample Name
Sample Code
 +2.18%
Sample Name
Sample Code
 +1.23%
4
CNOOC
00883
+1.15%
5
SINOPEC CORP
00386
-1.48%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +68.99%
Sample Name
Sample Code
 +59.23%
Sample Name
Sample Code
 +44.37%
4
Emdoor Information
001314
+43.99%
5
Digital China Group
000034
+29.13%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -